Brought to you by:
-
Changing course: The natural history of tibial claudication comes under scrutiny as interventions for ‘relatively benign’ disease trend upward
In the end, reflected Michael S. Conte, MD, “it’s not the evidence.” The leading vascular surgeon and peripheral arterial disease (PAD) expert made the bold statement during the recent 2023 VEITHsymposium (Nov. 14–18) as he pointedly asked a room full of colleagues: what is behind the trend that appears to show tibial interventions for intermittent…
-
Intravenous anesthesia delivery during varicose vein treatment proves safe and reduces pain scores, researcher reports
A new intravenous anesthesia delivery technique used during endothermal ablation for varicose veins demonstrated comparatively low pain scores according to first-in-human (FIH) data recently presented at the 2023 VEITHsymposium. The investigational Solutio catheter (MedVasc), which contains both a bent needle for tumescence deployment through the vessel wall into the perivascular space and endothermic fiber for…
-
SVS 2024 dues renewal deadline approaches
SVS members are reminded to act promptly before the year’s end to ensure uninterrupted access to their 2024 membership benefits. Renewals are due on or before the close of the year on Dec. 31. SVS members can pay their dues now by logging on at vascular.org/invoices. Renewal guarantees the continuation of all the benefits associated…
-
TRANSCEND 36-month data “continue to demonstrate safe and effective performance” of SurVeil DCB
Peter Schneider (University of California San Francisco, San Francisco, USA) recently presented 36-month data from Surmodics’ TRANSCEND clinical trial at the VEITHsymposium 2023 (14–18 November, New York, USA). The TRANSCEND trial is a prospective, multicentre, single-blind randomised controlled trial to assess the safety and efficacy of the SurVeil drug coated balloon (DCB; Surmodics) versus the…
-
SOOVC award initiatives offer opportunities to advance outpatient vascular care
The SVS Sub-Section on Outpatient and Office Vascular Care (SOOVC) has opened applications for its Presentation Award and Research Seed Grant, allowing practitioners to contribute to an ever-changing outpatient and office-based vascular care sector. The Presentation Award recognizes the work of vascular surgeons who have completed research projects in an office-based lab (OBL) or an…
-
VAM abstract submissions window opens
VAM program chair Andres Schanzer, MD, makes a call for cutting-edge new science for next year’s meeting in Chicago. Researchers who want to present new science at the 2024 Vascular Annual Meeting (VAM) are encouraged to prepare their abstracts for Nov. 15, when submissions open, to take advantage of the eight-week submission window. “What we’re…
-
Twelve-month first-in-human data from Xeltis’ aXess haemodialysis vascular conduit trial presented at VEITHsymposium 2023
Xeltis has announced “highly encouraging” 12-month results from its first-in-human (FIH) aXess vascular conduit trial. The data were presented by Frans Moll (University Medical Center Utrecht, Utrecht, The Netherlands) at this year’s VEITHsymposium (14–18 November, New York, USA). At 12 months, 100% secondary patency, 78% primary assisted patency and 0% infections were observed in data…
-
Randomized trial set to elucidate value of image fusion technology for aortic repair
An ongoing UK National Institute for Health and Care Research (NIHR)-funded randomized controlled trial seeks to illuminate the value of an image fusion guidance technology for endovascular aortic repair. In a presentation on the trial at this year’s VEITHsymposium (Nov. 14–18) in New York City, Rachel Clough, MD, a consultant vascular surgeon at King’s…
-
Two-year SWING data ‘continue to show promise’ for sirolimus DCB in treating BTK disease
Two-year data from the SWING trial, a first-in-human study of the safety and performance of the Sundance sirolimus drug-coated balloon (DCB; Surmodics), have been presented at this year’s VEITHsymposium (Nov. 14–18) in New York City. The SWING trial is a 35-patient prospective, multicenter, single-arm feasibility study to evaluate the safety and performance of the Sundance…
-
Specialty representation at all levels of a healthcare organization is ‘increasingly important’ in value-based systems
A 14-year effort to achieve departmental status for vascular surgery at a large healthcare system in Southern California resulted in significant gains for the specialty within the organizational apparatus, according to an administrative case report on an effort finalized last year. Jeffrey Hsu, MD, the regional chief of vascular surgery at Kaiser Permanente Southern California,…